Skip to main content

Green Eric Mark's Form 4 filing

West Pharmaceutical Services Inc (WST) · filed Feb 29, 2024

Accession no.
0001127602-24-007632
Filed
Feb 29, 2024
Trade date
Feb 27, 2024
Filing delay
2 days
Rule 10b5-1 plan
Checked

This filing lists 3 non-derivative transactions and 2 derivative transactions. Open-market sales total $23.1M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Green Eric MarkCIK 0001336007Director, Officer (President, CEO and Board Chair)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Feb 27, 2024Common StockMOption exerciseAcquired+64,132$57.38+$3,679,894.16217,040.12Direct
Feb 27, 2024Common StockSSaleDisposed−64,132$359.85−$23,077,900.2152,908.12Direct
Feb 27, 2024Common StockMOption exerciseAcquired+9,000$57.38+$516,420152,908.12Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Feb 27, 2024Common StockMOption exerciseDisposed−9,000$0.00$09,316Direct
Feb 27, 2024Common StockMOption exerciseDisposed−64,132$0.00$015,684Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)